StonvexLoading…
StonvexStonvexStonvexCore line items from BMRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $32.84M | $42.80M | $41.83M | $110.60M | $36.29M |
Operating Income | Not available | $11.60M | $-57.38M | $4.89M | $-11.20M |
Net Income | Not available | $8.51M | $-39.54M | $3.87M | $-8.54M |
EPS (Diluted) | $0.53 | $0.53 | $-2.49 | $0.24 | $-0.53 |
Total Assets | Not available | $3.91B | $3.90B | $3.87B | $3.73B |
Total Liabilities | Not available | $3.52B | $3.51B | $3.43B | $3.29B |
Cash & Equivalents | Not available | $236.64M | $225.30M | $219.33M | $228.86M |
Free Cash Flow OCF − CapEx | Not available | $921.00K | $37.26M | $23.76M | $11.70M |
Shares Outstanding | Not available | 16.19M | 16.10M | 16.09M | 16.12M |